Etiology


Pathogens

  • Escherichia coli: leading cause of UTI (approx. 80%)
    • Ten times more common in females (shorter urethras colonized by fecal microbiota).
  • Staphylococcus saprophyticus: 2nd leading cause of UTI in sexually active women
  • Klebsiella pneumoniae: 3rd leading cause of UTI
  • Proteus mirabilis
    • Produces ammonia, giving the urine a pungent or irritating smell
    • Associated with struvite stone formation
  • Nosocomial bacteria: Serratia marcescens, Enterococci spp., and Pseudomonas aeruginosa are associated with increased drug resistance.

Tip

  • Urethritis is often caused by sexually transmitted infections (STIs), e.g. N gonorrhoeae.
  • UTIs are generally caused by bacteria from the gastrointestinal tract, e.g. E coli.

Classification


FeatureUpper UTI (Pyelonephritis)Lower UTI (Cystitis)
LocationKidney / Renal PelvisBladder / Urethra
Systemic SxYes (Fever, Chills, Malaise)No (Typically Afebrile)
Key SignCVA Tenderness, Flank PainSuprapubic Tenderness
Urinary SxMay be presentPredominant (Dysuria, Frequency)
UA KEY FINDINGWBC CastsNO WBC Casts
SeverityMore SevereLess Severe
ManagementOften Inpatient, IV AntibioticsUsually Outpatient, Oral Antibiotics
![[highresdefault_L25856.jpghighresdefault_L25856.jpg]]

Clinical features


Diagnostics


Urinalysis

  • Pyuria: presence of white blood cells (WBCs) in the urine
    • Positive leukocyte esterase: an enzyme produced by WBC
    • ≥ 5 WBC/HPF
  • Bacteriuria: presence of bacteria in the urine
    • Positive urinary nitrites: indicate bacteria that convert nitrates to nitrites (most commonly gram-negative bacteria; e.g., E.coli, Klebsiella, Proteus mirabilis)
  • Other findings
    • Leukocyte casts may indicate pyelonephritis.
    • Micro- or macroscopic hematuria may be present.
    • Alkaline urine (pH > 8) and struvite crystals in sediment: indicate urease-producing organisms (e.g., Proteus, Klebsiella, Staphylococcus saprophyticus)

Transclude of Drawing-2025-03-29-16.01.03.excalidraw

Treatment


UTI in pregnancy


  • Pregnancy may increase the risk of recurrent bacteriuria and UTIs.
  • Treatment
    • Empiric antibiotics for ASB and lower UTI considered appropriate during pregnancy include:
      • Fosfomycin
      • Beta-lactam antibiotics for 5–7 days
        • Oral cephalosporins (e.g., cefpodoxime)
        • Aminopenicillins plus beta-lactamase inhibitors (e.g., amoxicillin/clavulanic acid)

Catheter-associated UTI (CAUTI)


  • Definitions
    • Catheter-associated UTI (CAUTI): symptomatic UTI occurring in a patient with an indwelling urinary catheter OR within 48 hours after removal of a urinary catheter
    • Catheter-associated asymptomatic bacteriuria (CAASB): bacteriuria (≥ 105CFU/mL) without symptoms in a patient with an indwelling urinary catheter OR within 48 hours after removal of a urinary catheter
  • Risk factors
    • Duration of catheter use, especially >48 hr (most important)
    • Female sex
    • Advanced age
    • Diabetes mellitus
  • Treatment
    • Catheter removal or replacement
      • Remove if no longer necessary.
      • Replace if still necessary and present for > 2 weeks.
    • Antibiotic therapy
      • Guided by culture results and local resistance patterns
      • Duration: typically 7–14 days depending on the resolution of symptoms